Tianjin Ringpu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Ringpu Bio-Technology Co Ltd with three other
companies in this sector in China:
Beijing SL Pharmaceutical Co Ltd
sales of 1.01 billion Chinese Renmimbi [US$146.57 million]
of which 98%
was Pharmaceuticals Industry),
Jiangxi Boya Bio-Pharmaceutical Co Ltd
(946.57 million Chinese Renmimbi [US$137.39 million]
of which 56%
was Blood Plasma), and
Zhongyuan Union Cell & Gene Engineering Corp Ltd
(835.64 million Chinese Renmimbi [US$121.28 million]
of which 61%
was Scientific research service).
During the year ended December of 2016, sales at
Tianjin Ringpu Bio-Technology Co Ltd were 969.68 million Chinese Renmimbi (US$140.74 million).
increase of 22.4%
versus 2015, when the company's sales were 792.32 million Chinese Renmimbi.
Sales of Other Operation saw an increase
41.3% in 2016, from
15.97 million Chinese Renmimbi to 22.57 million Chinese Renmimbi.